CA2396719A1 - 22 proteines humaines secretees - Google Patents

22 proteines humaines secretees Download PDF

Info

Publication number
CA2396719A1
CA2396719A1 CA002396719A CA2396719A CA2396719A1 CA 2396719 A1 CA2396719 A1 CA 2396719A1 CA 002396719 A CA002396719 A CA 002396719A CA 2396719 A CA2396719 A CA 2396719A CA 2396719 A1 CA2396719 A1 CA 2396719A1
Authority
CA
Canada
Prior art keywords
polypeptide
seq
cells
polynucleotide
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002396719A
Other languages
English (en)
Inventor
Craig A. Rosen
George A. Komatsoulis
Kevin P. Baker
Charles E. Birse
Daniel R. Soppet
Henrik S. Olsen
Paul A. Moore
Ping Wei
Reinhard Ebner
D. Roxanne Duan
Yanggu Shi
Gil H. Choi
Michele Fiscella
Jian Ni
Steven M. Ruben
Steven C. Barash
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2396719A1 publication Critical patent/CA2396719A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA002396719A 2000-01-31 2001-01-17 22 proteines humaines secretees Abandoned CA2396719A1 (fr)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US17906500P 2000-01-31 2000-01-31
US60/179,065 2000-01-31
US18062800P 2000-02-04 2000-02-04
US60/180,628 2000-02-04
US22627900P 2000-08-18 2000-08-18
US60/226,279 2000-08-18
US25198800P 2000-12-05 2000-12-05
US60/251,988 2000-12-05
US25967801P 2001-01-05 2001-01-05
US60/259,678 2001-01-05
PCT/US2001/001434 WO2001054708A1 (fr) 2000-01-31 2001-01-17 22 proteines humaines secretees

Publications (1)

Publication Number Publication Date
CA2396719A1 true CA2396719A1 (fr) 2001-08-02

Family

ID=27539005

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002396719A Abandoned CA2396719A1 (fr) 2000-01-31 2001-01-17 22 proteines humaines secretees

Country Status (4)

Country Link
EP (1) EP1251863A4 (fr)
AU (1) AU2001237958A1 (fr)
CA (1) CA2396719A1 (fr)
WO (1) WO2001054708A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1309684A2 (fr) * 2000-06-27 2003-05-14 Curagen Corporation Polynucleotides et polypeptides codes par ceux-ci
WO2002051438A2 (fr) * 2000-12-22 2002-07-04 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Utilisation de rgm et de ses modulateurs
JP3910536B2 (ja) * 2000-12-28 2007-04-25 塩野義製薬株式会社 新規ポリペプチドおよびそのdna
WO2002101075A2 (fr) 2001-06-13 2002-12-19 Millennium Pharmaceuticals, Inc. Identification, evaluation, prevention et traitement du cancer du col de l'uterus : nouveaux genes, nouvelles compositions, nouvelles trousses et nouvelles methodes
JP2003245084A (ja) 2001-12-20 2003-09-02 Morinaga Milk Ind Co Ltd 脳梁又は精子の形成不全の診断及び治療に有用な新規遺伝子、並びにその用途
EP1490108A4 (fr) 2002-04-18 2006-08-09 Gen Hospital Corp Famille de genes drg11 (dragon)
WO2004020465A2 (fr) * 2002-09-02 2004-03-11 DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung Proteines intervenant dans la regulation de l'homeostasie energetique
AU2015242979B2 (en) * 2002-11-22 2016-12-01 Ganymed Pharmaceuticals Ag Genetic products differentially expressed in tumors and the use thereof
DE10254601A1 (de) 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
DE102004024617A1 (de) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
AU2013260709C1 (en) * 2004-05-18 2016-09-08 Astellas Pharma Inc. Genetic products differentially expressed in tumors and the use thereof
JP5063366B2 (ja) 2005-02-16 2012-10-31 ザ ジェネラル ホスピタル コーポレイション ヘプシジンによる鉄代謝を制御するためのTGF−βスーパーファミリーの化合物の調節因子の使用
EP1928905B1 (fr) 2005-09-30 2015-04-15 AbbVie Deutschland GmbH & Co KG Domaines de liaison de proteines de la famille proteinique des molecules de guidage repulsif (rgm), fragments fonctionnels de ces domaines et leur utilisation
EP1790664A1 (fr) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Anticorps monoclonaux contre claudin-18 pour le traitement du cancer
US8895002B2 (en) 2007-04-09 2014-11-25 The General Hospital Corporation Hemojuvelin fusion proteins and uses thereof
US8962803B2 (en) 2008-02-29 2015-02-24 AbbVie Deutschland GmbH & Co. KG Antibodies against the RGM A protein and uses thereof
BR112012013734A2 (pt) 2009-12-08 2017-01-10 Abbott Gmbh & Co Kg anticorpos monoclonais contra a proteína rgm a para uso no tratamento da degeneração da camada de fibras nervosas da retina.
IL297229A (en) 2012-01-27 2022-12-01 Abbvie Inc The composition and method for the diagnosis and treatment of diseases related to the degeneration of nerve cells
WO2013167153A1 (fr) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Anticorps utiles dans le diagnostic du cancer
WO2013174404A1 (fr) 2012-05-23 2013-11-28 Ganymed Pharmaceuticals Ag Polythérapie impliquant des anticorps dirigés contre la claudine 18,2 pour le traitement du cancer
RU2678127C2 (ru) 2012-11-13 2019-01-23 Бионтех Аг Агенты для лечения экспрессирующих клаудин раковых заболеваний
WO2014127785A1 (fr) 2013-02-20 2014-08-28 Ganymed Pharmaceuticals Ag Polythérapie impliquant des anticorps dirigés contre la claudine 18,2 pour le traitement du cancer
WO2014146672A1 (fr) 2013-03-18 2014-09-25 Ganymed Pharmaceuticals Ag Thérapie comprenant des anticorps dirigés contre cldn 18.2 pour le traitement du cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000012708A2 (fr) * 1998-09-01 2000-03-09 Genentech, Inc. Nouveaux pro-polypeptides et sequences correspondantes
WO2000015659A2 (fr) * 1998-09-16 2000-03-23 Zymogenetics, Inc. Polypeptide stomacal zsig28

Also Published As

Publication number Publication date
WO2001054708A1 (fr) 2001-08-02
EP1251863A4 (fr) 2005-03-02
EP1251863A1 (fr) 2002-10-30
AU2001237958A1 (en) 2001-08-07

Similar Documents

Publication Publication Date Title
US7196164B2 (en) Secreted protein HHTLF25
US20090042792A1 (en) 18 human secreted proteins
CA2396719A1 (fr) 22 proteines humaines secretees
US20050208565A1 (en) 29 human cancer associated proteins
WO2001051504A1 (fr) Proteines humaines secretees 71
US20030203361A1 (en) 13 human colon and colon cancer associated proteins
US20050032168A1 (en) 17 human secreted proteins
US7091315B1 (en) Protein HDPBQ71
US20060057582A1 (en) 83 human secreted proteins
US20030113840A1 (en) 25 human secreted proteins
US20030083481A1 (en) 25 human prostate and prostate cancer associated proteins
US20050208619A1 (en) 29 human secreted proteins
US20030152933A1 (en) Human secreted proteins
EP1317471A1 (fr) 21 proteines humaines secretees
EP1322657A1 (fr) Proteines secretees humaines 22
EP1317472A1 (fr) 17 proteines humaines secretees
EP1322659A1 (fr) 21 proteines humaines secretees
WO2002026931A2 (fr) 71 proteines humaines secretees
WO2002018435A1 (fr) 18 protéines humaines sécrétées
WO2002024721A1 (fr) 21 proteines humaines secretees
EP1317473A1 (fr) 17 proteines humaines secretees
EP1317469A1 (fr) 21 proteines humaines secretees
EP1325021A1 (fr) 12 proteines humaines secretees
WO2002016389A1 (fr) 23 proteines humaines secretees
WO2002028877A1 (fr) 24 proteines humaines secretees

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued